Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

We accrued 201 patients of adult AML treated with conventional therapy, in morphological remission, and evaluated MRD using sensitive error-corrected next generation sequencing (NGS-MRD) and multiparameter flow cytometry (FCM-MRD) at the end of induction (PI) and consolidation (PC). Nearly 71% of pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Leukemia
Hlavní autoři: Patkar, Nikhil, Kakirde, Chinmayee, Shaikh, Anam Fatima, Salve, Rakhi, Bhanshe, Prasanna, Chatterjee, Gaurav, Rajpal, Sweta, Joshi, Swapnali, Chaudhary, Shruti, Kodgule, Rohan, Ghoghale, Sitaram, Deshpande, Nilesh, Shetty, Dhanalaxmi, Khizer, Syed Hasan, Jain, Hasmukh, Bagal, Bhausaheb, Menon, Hari, Khattry, Navin, Sengar, Manju, Tembhare, Prashant, Subramanian, Papagudi, Gujral, Sumeet
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102181/
https://ncbi.nlm.nih.gov/pubmed/33558666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-021-01131-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky